NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals, Inc.verified

NRXP

Price:

$1.26

Market Cap:

$15.24M

NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington, Delaware.[Read more]

Industry

Biotechnology

IPO Date

2017-12-04

Stock Exchange

NASDAQ

Ticker

NRXP

The Enterprise Value as of November 2024 (TTM) for NRx Pharmaceuticals, Inc. (NRXP) is 20.26M

According to NRx Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 20.26M. This represents a change of -83.79% compared to the average of 124.98M of the last 4 quarters.

NRx Pharmaceuticals, Inc. (NRXP) Historical Enterprise Value (quarterly & annually)

How has NRXP Enterprise Value performed in the past?

The mean historical Enterprise Value of NRx Pharmaceuticals, Inc. over the last ten years is 1.64B. The current 20.26M Enterprise Value has changed 23.41% with respect to the historical average. Over the past ten years (40 quarters), NRXP's Enterprise Value was at its highest in in the March 2021 quarter at 12.63B. The Enterprise Value was at its lowest in in the December 2019 quarter at 3.08M.

Quarterly (TTM)
Annual

Average

1.64B

Median

91.71M

Minimum

8.30M

Maximum

8.36B

NRx Pharmaceuticals, Inc. (NRXP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of NRx Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 14.86%

Maximum Annual Enterprise Value = 8.36B

Minimum Annual Increase = -94.53%

Minimum Annual Enterprise Value = 8.30M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202339.42M-94.53%
2022720.48M-67.48%
20212.22B-73.50%
20208.36B14.86%
201955.89M-39.06%
201891.71M1.01%

NRx Pharmaceuticals, Inc. (NRXP) Average Enterprise Value

How has NRXP Enterprise Value performed in the past?

The current Enterprise Value of NRx Pharmaceuticals, Inc. (NRXP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

991.83M

5-year avg

2.28B

10-year avg

1.64B

NRx Pharmaceuticals, Inc. (NRXP) Enterprise Value vs. Peers

How is NRXP’s Enterprise Value compared to its peers?

NRx Pharmaceuticals, Inc.’s Enterprise Value is less than BiomX Inc. (0), greater than Lexaria Bioscience Corp. (-3889206.00), less than Aditxt, Inc. (28.16M), greater than Nutriband Inc. (14.61M), less than Quoin Pharmaceuticals, Ltd. (0), less than Longeveron Inc. (46.88M), greater than RenovoRx, Inc. (-162664.00), greater than Virax Biolabs Group Limited (6.86M), less than SAB Biotherapeutics, Inc. (21.40M), greater than Senti Biosciences, Inc. (5.36M), less than Cingulate Inc. (24.24M), less than Bellicum Pharmaceuticals, Inc. (34.09M), greater than Hillstream BioPharma, Inc. (5.36M), greater than null (-5130674.00), greater than null (1.48M),

Build a custom stock screener for NRx Pharmaceuticals, Inc. (NRXP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NRx Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NRx Pharmaceuticals, Inc. (NRXP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NRx Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is NRx Pharmaceuticals, Inc.'s Enterprise Value?

What is the highest Enterprise Value for NRx Pharmaceuticals, Inc. (NRXP)?

What is the 3-year average Enterprise Value for NRx Pharmaceuticals, Inc. (NRXP)?

What is the 5-year average Enterprise Value for NRx Pharmaceuticals, Inc. (NRXP)?

How does the current Enterprise Value for NRx Pharmaceuticals, Inc. (NRXP) compare to its historical average?